Kemi Olugemo

Kemi Olugemo, MD, FAAN, currently serves as Chief at the private network empowering executive women since December 2021. With extensive experience in the biotechnology and pharmaceutical sectors, Kemi held the position of Chief Medical Officer at Korro Bio, Inc., where a focus on RNA editing technology is utilized to address challenging diseases. Prior roles include Vice President of Global Clinical Development at Ultragenyx, and Vice President and Head of Clinical Development at Laronde. Kemi's career includes significant leadership positions at Ionis Pharmaceuticals, Parexel, Quorum Review IRB, Mallinckrodt Pharmaceuticals, and a partnership at the University of Maryland Charles Regional Medical Center. Kemi holds an M.D. from the University of Maryland School of Medicine and a B.S. in Clinical Laboratory Science from the University of Massachusetts Lowell, along with an International Baccalaureate from the International School Groningen.